Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint-Denis, 93200, France.
Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK.
J Cardiothorac Surg. 2024 Sep 5;19(1):514. doi: 10.1186/s13019-024-03002-4.
Type A acute aortic dissection (TAAAD) is a deadly condition that demands immediate surgery, because it involves a critically. The mortality and morbidity associated with it are significant, and it is vital that the patient's conditions and treatment strategies are fully understood to ensure the appropriate management of TAAAD. This study aims to ascertain whether hemiarch repair (HAR) versus extended arch repair (EAR) with or without descending aortic intervention results in better perioperative and late outcomes for patients with TAAAD.
Four leading centers of cardiac surgery from two European countries have joined forces to create a groundbreaking multicenter observational registry (AoArch). This study was approved by the institutional review board (IRB 202201173). We conducted a retrospective review (NCT00591263) of our prospectively maintained database for patients who underwent operative repair of DeBakey type I or type II dissection from January 1, 2005 to March 2024 (NCT05927090). We will analyze how patient co-morbidities, referral conditions, and surgical strategies involving hemi-arch repair (HAR) and extended arch repair (EAR) impact early and late adverse events. We have developed a procedure urgency algorithm based on the severity of preoperative hemodynamic conditions and malperfusion due to TAAAD, and we will use it to assess the primary clinical outcomes: in-hospital mortality, late mortality, and reoperations on the aorta. We will define secondary outcomes as permanent neurologic deficit, the need for new dialysis, respiratory failure, a composite of major adverse events (myocardial infarction, cerebrovascular accidents, the need for dialysis, or the need for tracheostomy), and a composite of major adverse pulmonary events (intubation over 48 h, pneumonia, reintubation, tracheostomy), and reoperation due to bleeding.
This multicenter registry will definitively determine the prognostic significance of critical preoperative conditions and the efficacy of extended arch interventions and hemiarch repair in reducing the risk of early adverse events after surgery for TAAAD. This registry will provide insights into the long-term durability of different strategies of surgical repair for TAAAD.
A型急性主动脉夹层(TAAAD)是一种致命的疾病,需要立即手术,因为它涉及到危急情况。与 TAAAD 相关的死亡率和发病率都很高,因此充分了解患者的病情和治疗策略至关重要,以确保对 TAAAD 进行适当的管理。本研究旨在确定半弓修复(HAR)与扩展弓修复(EAR)加或不加降主动脉干预对 TAAAD 患者的围手术期和晚期结果是否更好。
来自两个欧洲国家的四家心脏外科领先中心联手创建了一个开创性的多中心观察性注册中心(AoArch)。该研究得到了机构审查委员会(IRB 202201173)的批准。我们对我们前瞻性维护的数据库进行了回顾性审查(NCT00591263),纳入了 2005 年 1 月 1 日至 2024 年 3 月期间接受 DeBakey Ⅰ型或Ⅱ型夹层手术修复的患者(NCT05927090)。我们将分析患者合并症、转诊情况以及涉及半弓修复(HAR)和扩展弓修复(EAR)的手术策略如何影响早期和晚期不良事件。我们根据 TAAAD 引起的术前血流动力学状况和灌注不良的严重程度制定了一个手术紧迫性算法,并将其用于评估主要临床结局:住院死亡率、晚期死亡率和主动脉再手术。我们将定义次要结局为永久性神经功能缺损、需要新透析、呼吸衰竭、主要不良事件(心肌梗死、中风、需要透析或需要气管切开术)的复合事件以及主要不良肺部事件(插管超过 48 小时、肺炎、再插管、气管切开术)的复合事件,以及由于出血导致的再手术。
该多中心注册中心将明确确定术前关键条件的预后意义以及扩展弓干预和半弓修复在降低 TAAAD 手术后早期不良事件风险方面的疗效。该注册中心将提供有关 TAAAD 不同手术修复策略的长期耐久性的见解。